Meeder Asset Management’s Biohaven BHVN Stock Holding History

Meeder Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-118	Closed	-$17K	–	923
2022 Q3	$17K	Buy	+118	New	+$856	﹤0.01%	1148

Other funds holding BHVN

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Meeder Asset Management's BHVN Position: Q4 2022 in Review

Meeder Asset Management sold out of Biohaven (BHVN) in Q4 2022, closing a stake of 118 shares — an estimated $17K sold.

Meeder Asset Management first reported a position in BHVN in Q3 2022 and held it in 1 quarter. The position peaked at $17K in Q3 2022. 176 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

Meeder Asset Management reported no remaining Biohaven position as of Q4 2022 after selling out during the quarter.
Meeder Asset Management sold 118 Biohaven shares in Q4 2022, an estimated $17K.
Meeder Asset Management first reported a position in Biohaven in Q3 2022 and held it in 1 quarter.
Meeder Asset Management's Biohaven position peaked at $17K in Q3 2022.
176 funds tracked by Wall St. Rank held Biohaven as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.